adebrelimab

Key facts

Mechanism of action

Programmed cell death 1 ligand 1 inhibitor

Primary target: Programmed cell death 1 ligand 1

Approval history

1. chemotherapy and SHR-1316(Adebrelimab) comnined with surgery or radiotherapy Phase 3 · Chinese Academy of · Limited Stage Small Cell Lung Cancer
2. 2024-HS-022 Phase 2 · First People's Hospital · Platinum-sensitive Relapsed Ovarian Cancer
3. Adebrelimab Phase 2 · Chinese Academy of · Pancreatic Cancer
4. Adebrelimab (PD-L1 inhibitor) Phase 2 · Chinese Academy of · Pancreatic Cancer Metastatic
5. Adebrelimab+Albumin paclitaxel +Cisplatin Phase 2 · First People's Hospital · Locally Advanced Hypopharyngeal Cancer
6. NALIRIFOX+Adebrelimab Phase 2 · Chinese Academy of · Pancreatic Ductal Adenocarcinoma (PDAC)
7. PC-IIT-003 Phase 2 · First People's Hospital · Pancreatic Cancer
8. SHR-A1921 injection and adebrelimab injection Phase 2 · Chinese Academy of · NSCLC

1. atezolizumab Antineoplastic and immunomodulating agents (L01)
2. avelumab Antineoplastic and immunomodulating agents (L01)
3. cosibelimab-ipdl Programmed cell death 1 ligand 1 inhibitor
4. durvalumab Antineoplastic and immunomodulating agents (L01)
5. sugemalimab Antineoplastic and immunomodulating agents (L01)
6. envafolimab Programmed cell death 1 ligand 1 binding agent

Frequently asked questions